Marketing-authorisation holder · United States
Neurocrine
4 medicines in 1 country, as authorisation holder.
Group structure
Other companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CRENESSITY100mg | 25mg | 50mg · Capsule | Crinecerfont | United States | Marketed | 2024 |
| CRENESSITY50mg/ml · Solution | Crinecerfont | United States | Marketed | 2024 |
| INGREZZA40mg base | 60mg base | 80mg base · Capsule | Valbenazine | United States | Marketed | 2017 |
| INGREZZA SPRINKLE40mg base | 60mg base | 80mg base · Capsule | Valbenazine | United States | Marketed | 2024 |